Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)

FDA Drug Profile — North American Coral Snake Antivenin (Equine)

Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine) is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including North American Coral Snake Antivenin (Equine). Available dosage form: injection, powder, for solution.

Drug details

Generic Name
Coral Snake (Micrurus Fulvius) Immune Globulin Antivenin (Equine)
Brand Names
North American Coral Snake Antivenin (Equine)
Application Number
BLA101099
Sponsor
Wyeth Pharmaceuticals LLC, A Subsidiary Of Pfizer Inc.
NDC Codes
1
Dosage Forms
INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients
CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)

Indications and Usage

1 INDICATIONS AND USAGE North American Coral Snake Antivenin (Equine) is indicated only for the treatment of envenomation caused by bites of North American coral snakes - Micrurus (including the eastern and Texas varieties). North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snakes - Micrurus . ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.